Experts gather for HRI Centre for Peripheral Artery Disease (PAD) Colloquium
The Heart Research Institute (HRI) Centre for Peripheral Artery Disease (PAD) has held its inaugural colloquium, bringing together leading experts in PAD from around Australia.
HRI's Dr Xuyu Liu awarded funding for research into new stroke treatments
Congratulations to Dr Xuyu (Johnny) Liu, Unit Leader at the Heart Research Institute (HRI), who has been awarded funding from the Hillcrest Foundation and the Walter and Eileen Ralston Trust.
The HRI Centre for PAD on a mission to help Australians living with peripheral artery disease
The Heart Research Institute Centre for PAD is the first of its kind in NSW, paving the way for world-leading research and helping to raise awareness about the debilitating condition.
Printing healthy hearts and saving lives at HRI
Scientists from the Heart Research Institute (HRI) are developing a world-first alternative to heart transplants, using “mini-hearts” and a bioprinter.
HRI celebrates 35 years of groundbreaking research
The Heart Research Institute (HRI) is celebrating 35 years of world-renowned research.
HRI scientists investigate new drug to shield breast cancer patients from heart damage
In an Australian first, researchers at the Heart Research Institute (HRI) are using lab-grown ‘mini-hearts’ as they work to develop a new drug to protect breast cancer patients from potentially life-threatening heart complications caused by chemotherapy.
Meet the Team: Dr Clara Liu
Dr Clara Liu Chung Ming is one of HRI’s outstanding Early Career Researchers, working as a Research Officer in Professor Julie McMullen’s Heart Muscle Laboratory focusing on cardio-oncology and breast cancer.
Penrith Selective High School students gain hands-on experience at HRI
The Heart Research Institute (HRI) recently had the pleasure of hosting three Year 10 students from Penrith Selective High School as part of their work experience program.
Scientists to reverse deadly drop in blood pressure that triggers septic shock
A team of researchers at the Heart Research Institute (HRI) in Sydney is working to develop a first of its kind treatment for the cardiovascular complications of septic shock, one of the world’s deadliest conditions.